Clinical trial
Blood Collection Biorepository for Liver Disease Research
Recruiting now · Not applicable · 1 countries · Registry ID NCT03025074
Recruiting nowNot applicableObservational
What this study is about
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age7 Years to Not listed
SexAll
Healthy volunteersAccepted
ConditionNon-Alcoholic Steatohepatitis(NASH), Hepatitis C, Hepatitis B, Fibrosis, Cirrhosis, Fatty Liver, Obesity, Childhood, Bariatric Surgery Candidate
Full registry criteria
Inclusion Criteria: * This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples. * Children and teenagers will be special populations considered in this protocol. Exclusion Criteria: * Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.
Treatments and study arms
The registry does not list a named intervention.
Primary outcomes
Number of samples collected52 weeks
Total number of samples collected
Study locations
1 locations were listed when this page was built. The first 40 are shown.
University at Buffalo, Buffalo General Medical Center🇺🇸 Buffalo, New York, United States
Barbara Bauer, BAContact